Social Media Influencers Driving Unofficial Market for Unapproved Slimming Drug

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day British shipping. Sellers promote the substance there before directing buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Several professionals said the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the service has removed problematic content and banned related keywords and search suggestions. The organization stated it was committed to maintaining the service safe and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand participants selling retatrutide using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, populated with images of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of joining one group, a vendor posted contact information, where most purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, health issues or past usage.

Product Details and Pricing

Within these groups, messages show black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has already seen individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to potentially serious health risks”.